Abstract
Oral administration of 1 g of 3-hydroxy-3-methylglutaric acid (HMG) before the ingestion of whiskey and a fatty meal markedly reduced the elevation of serum triglycerides, β-lipoproteins, phospholipids, and cholesterol in man. In rats receiving an ethanol and corn oil mixture, HMG also inhibited the increase in postprandial serum and liver lipids. A comparative study of HMG and nicotinic acid in rats showed that, therapeutically, 50 mg MHG/kg body weight is equivalent to 200 mg nicotinic acid/kg body weight in offering almost total protection against lipemic effects of ethanol.
Similar content being viewed by others
References
Talbott, G.D., and B.M. Keating, Geriatrics 17:802 (1962).
Brewster, A.C., N.G. Lankford, M.G. Schwartz, and J.F. Sullivan, Am. J. Clin. Nutr. 19:225 (1966).
Verdy, M., and A. Gattereu, Ibid. 20:997 (1967).
Barboriak, J.J., and R.D. Meade, Am. J. Med. Sci. 255:245 (1968).
McMohon, F.G., and J.R. Ryan, J. La. State Med. Soc. 121:181 (1969).
Wilson, E.D., D.H. Schreibman, A.C. Brewster, and R.A. Arky, J. Lab. Clin. Med. 75:265 (1970).
Diluzio, N.R., and M. Poggi, Life Sci. 2:751 (1963).
Barboriak, J.J., and R.C. Meade, Q. J. Stud. Alcohol 29:238 (1968).
Barboriak, J.J., and R.C. Meade, Atherosclerosis 13:199 (1971).
Beg, Z.H., and M. Siddiqi, Experientia 23:380 (1967).
Beg, Z.H., and M. Siddiqi, Ibid. 24:791 (1968).
Lupien, P.J., M. Tremblay, and Z.H. Beg, Atherosclerosis 18:407 (1973).
Yusufi, A.N.K., and M. Siddiqi Ibid. 20:517, (1974).
Lupien, P.J., D. Brun, and S. Moorjani, Lancet 101, II:1256 (1973).
Zlatkis, A., B. Zak, and A.J. Boyle, J. Lab. Clin. Med. 4:486 (1953).
Marinetti, G.V., J. Lipid Res. 3:1 (1962).
Van Handel, E., and D.B. Zilversmit, J. Lab. Clin. Med. 50:152 (1957).
Voelker, U.F., Ger. Offen. 2,013:644 (1971).
Varley, H., “Practical Clinical Biochemistry,” 4th Edition, ELBS and William Heinemann Medical Book Ltd., Great Britain, 1969, p. 733.
Folch, J., M. Lees, and G.H.S. Stanley, J. Biol. Chem. 226:496 (1957).
Bloor, W.R., K.F. Pelkan, and D.M. Aleen, Ibid. 52:191 (1922).
Barboriak, J.J., Q.J. Studies Alcohol 35:15 (1974).
Mendleson, J.H., and N.K. Mello, Science 180:1372 (1973).
Kuo, P.T., Med. Clin. North. Am. 58:351 (1974).
Kallio, V., H. Saarima, and A. Saarima, Q.J. Studies Alcohol 30:565 (1969).
Fimognari, G.M., “Mevalonate Biosynthesis,” Ph.D Thesis, University of California, San Francisco, CA, 1964, p. 78.
Beg, Z.H., and P.J. Lupien, Biochim. Biophys. Acta 260:439 (1972).
Maragoudakis, M.E., J. Biol. Chem. 244:5005 (1969).
Dekker, S.E., M.J. Schlesinger, and M.J. Coon, Ibid. 233:791 (1958).
Author information
Authors and Affiliations
Additional information
U.S. Patent 3,629,449 (Dec. 21, 1971) on “Process of Combatting Hypercholesterolemia”.
About this article
Cite this article
Yousufzai, S.Y.K., Siddiqi, M. & Abdullah, A.K. Protective effect of 3-hydroxy-3-methylglutaric acid in alcohol-induced lipemia. Lipids 11, 526–529 (1976). https://doi.org/10.1007/BF02532897
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02532897